These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26757598)

  • 21. Variants in DENND1A and LHCGR are associated with endometrioid adenocarcinoma.
    Wang Z; Li T; Zhang W; You L; Zhao Y; Xia M; Zhao H; Chen ZJ
    Gynecol Oncol; 2012 Nov; 127(2):403-5. PubMed ID: 22902918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals.
    Brower MA; Jones MR; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E182-6. PubMed ID: 25303487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP1A1 gene polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
    Shen W; Li T; Hu Y; Liu H; Song M
    Genet Test Mol Biomarkers; 2013 Oct; 17(10):727-35. PubMed ID: 23848208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21, and 9q33.3 in a cohort of Caucasian women.
    Lerchbaum E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
    Horm Metab Res; 2011 Oct; 43(11):743-7. PubMed ID: 22009367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.
    McAllister JM; Han AX; Modi BP; Teves ME; Mavodza GR; Anderson ZL; Shen T; Christenson LK; Archer KJ; Strauss JF
    Endocrinology; 2019 Aug; 160(8):1964-1981. PubMed ID: 31184707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four polymorphisms of the CAPN 10 gene and their relationship to polycystic ovary syndrome susceptibility: a meta-analysis.
    Huang M; Xiao J; Zhao X; Liu C; Chen Q
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):431-8. PubMed ID: 21906115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.
    Zhao H; Xu X; Xing X; Wang J; He L; Shi Y; Shi Y; Zhao Y; Chen ZJ
    Hum Reprod; 2012 Jan; 27(1):294-8. PubMed ID: 22081247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dennd1a, a susceptibility gene for polycystic ovary syndrome, is essential for mouse embryogenesis.
    Shi J; Gao Q; Cao Y; Fu J
    Dev Dyn; 2019 May; 248(5):351-362. PubMed ID: 30884041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of DENND1A and CYP19A1 gene variants in individual susceptibility to obesity in Turkish population-a preliminary study.
    Kadioglu E; Altun B; İpek Ç; Döğer E; Bideci A; Attaran H; Çok İ
    Mol Biol Rep; 2018 Dec; 45(6):2193-2199. PubMed ID: 30232779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis.
    Liu Z; Wang Z; Hao C; Tian Y; Fu J
    Reprod Biol Endocrinol; 2018 Dec; 16(1):120. PubMed ID: 30509295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the Genetic Polymorphisms rs6259 and rs727428 of the
    Liao X; Cao S
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):492-501. PubMed ID: 32589470
    [No Abstract]   [Full Text] [Related]  

  • 32. Meta-analysis of the correlation between the TNF-α308G/A polymorphism and polycystic ovary syndrome.
    Liu XB; Deng XH; Zhou B; Zhang L; Niu XM
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility loci identified in Han Chinese influence genetic predisposition of PCOS in Indian women.
    Dadachanji R; Khavale S; Joshi N; Patil A; Mukherjee S
    Mol Biol Rep; 2024 Jan; 51(1):160. PubMed ID: 38252377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: A systematic review and meta-analysis.
    Shi X; Xie X; Jia Y; Li S
    J Obstet Gynaecol Res; 2016 Jul; 42(7):844-54. PubMed ID: 27098445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between two polymorphisms of follicle stimulating hormone receptor gene and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Qiu L; Liu J; Hei QM
    Chin Med Sci J; 2015 Mar; 30(1):44-50. PubMed ID: 25837360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of vascular endothelial growth factor polymorphisms with polycystic ovarian syndrome risk: a meta-analysis.
    Zhao J; Li D; Tang H; Tang L
    Reprod Biol Endocrinol; 2020 Mar; 18(1):18. PubMed ID: 32164758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two follicle-stimulating hormone receptor polymorphisms and polycystic ovary syndrome risk: a meta-analysis.
    Chen DJ; Ding R; Cao JY; Zhai JX; Zhang JX; Ye DQ
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():27-32. PubMed ID: 25218548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.
    McAllister JM; Modi B; Miller BA; Biegler J; Bruggeman R; Legro RS; Strauss JF
    Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1519-27. PubMed ID: 24706793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis.
    Ruan Y; Ma J; Xie X
    Endocr J; 2012; 59(7):601-9. PubMed ID: 22523112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative splicing of DENND1A, a PCOS candidate gene, generates variant 2.
    Tee MK; Speek M; Legeza B; Modi B; Teves ME; McAllister JM; Strauss JF; Miller WL
    Mol Cell Endocrinol; 2016 Oct; 434():25-35. PubMed ID: 27297658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.